Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ishikawa

Showing results (381-390 of 404) with videos related to

Pageof 41
Sort By:
International Journal of Molecular Sciences|July 14, 2023
A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy ResultsNoriyuki Okonogi, Kazutoshi Murata, Shigeru Yamada, et al.
Anticancer Research|August 19, 2007
Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomographyHiroyuki Kato, Minoru Fukuchi, Tatsuya Miyazaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 30, 2024
Japanese clinical practice guidelines for prostate cancer 2023Yasuo Kohjimoto, Hiroji Uemura, Masahiro Yoshida, et al.
International Cancer Conference Journal|April 3, 2026
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinomaHaruka Anzai, Chihiro Miwa, Sadahisa Ogasawara, et al.
JHEP Reports : Innovation in Hepatology|March 29, 2026
MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
Abnormal pupillary light reflex with chromatic pupillometry in Gaucher diseaseAya Narita, Kentarou Shirai, Norika Kubota, et al.
European Urology|January 18, 2026
Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 TrialYoshiyuki Nagumo, Tomokazu Kimura, Hitoshi Ishikawa, et al.
Esophagus : Official Journal of the Japan Esophageal Society|May 13, 2026
Nationwide quality indicator survey on the current practice of esophageal cancer management in Japan: report from the guideline committee for the 6th edition of the Japanese Esophageal Cancer Practice GuidelinesEisuke Booka, Hiroya Takeuchi, Ryu Ishihara, et al.
Esophagus : Official Journal of the Japan Esophageal Society|June 16, 2023
Concurrent chemoradiotherapy using proton beams can reduce cardiopulmonary morbidity in esophageal cancer patients: a systematic reviewTetsuo Nonaka, Shohei Kawashiro, Hitoshi Ishikawa, et al.
Archives of Microbiology|October 18, 2025
Intranasal phage therapy overcomes antibody neutralization challenges in pulmonary Pseudomonas aeruginosa infectionsDhammika Leshan Wannigama, Jingping Shao, Hongya Sun, et al.
Pageof 41

Showing results (381-390 of 404) with videos related to

Sort By:
Pageof 41
International Journal of Molecular Sciences|July 14, 2023
A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy ResultsNoriyuki Okonogi, Kazutoshi Murata, Shigeru Yamada, et al.
Anticancer Research|August 19, 2007
Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomographyHiroyuki Kato, Minoru Fukuchi, Tatsuya Miyazaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 30, 2024
Japanese clinical practice guidelines for prostate cancer 2023Yasuo Kohjimoto, Hiroji Uemura, Masahiro Yoshida, et al.
International Cancer Conference Journal|April 3, 2026
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinomaHaruka Anzai, Chihiro Miwa, Sadahisa Ogasawara, et al.
JHEP Reports : Innovation in Hepatology|March 29, 2026
MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
Abnormal pupillary light reflex with chromatic pupillometry in Gaucher diseaseAya Narita, Kentarou Shirai, Norika Kubota, et al.
European Urology|January 18, 2026
Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 TrialYoshiyuki Nagumo, Tomokazu Kimura, Hitoshi Ishikawa, et al.
Esophagus : Official Journal of the Japan Esophageal Society|May 13, 2026
Nationwide quality indicator survey on the current practice of esophageal cancer management in Japan: report from the guideline committee for the 6th edition of the Japanese Esophageal Cancer Practice GuidelinesEisuke Booka, Hiroya Takeuchi, Ryu Ishihara, et al.
Esophagus : Official Journal of the Japan Esophageal Society|June 16, 2023
Concurrent chemoradiotherapy using proton beams can reduce cardiopulmonary morbidity in esophageal cancer patients: a systematic reviewTetsuo Nonaka, Shohei Kawashiro, Hitoshi Ishikawa, et al.
Archives of Microbiology|October 18, 2025
Intranasal phage therapy overcomes antibody neutralization challenges in pulmonary Pseudomonas aeruginosa infectionsDhammika Leshan Wannigama, Jingping Shao, Hongya Sun, et al.
Pageof 41